Abstract: The present invention is directed to imidazolyl derivatives of formula (II), wherein the variables are defined in the specification, which are useful as prenyl transeferase inhibitors.
Type:
Application
Filed:
January 21, 2003
Publication date:
January 1, 2004
Applicant:
Societe de Conseils de Recherches et D'Application Scientefiques, S.A.S., a France corporation
Abstract: The present invention is directed to peptide analogues of fragment of parathyroid hormone (PTH) or parathyroid hormone-related protein (PTHrP), a method of using said analogues alone or in combination with a bisphosphonate or calcitonin to treat osteoporosis and pharmaceutical compositions comprising said analogues alone or in combination with a bisphosphonate or calcitonin.
Type:
Application
Filed:
November 6, 2002
Publication date:
September 4, 2003
Applicant:
Societe de Conseils de Recherches et D'Application Scientefiques, S.A.S., a France corporation